RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges
Tweet Send to a Friend
Stifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $7.00 (from $8.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
